Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...

AstraZeneca's Fasenra has been cleared for use by the NHS in England as an add-on treatment for the rare autoimmune disease ...

Britain’s cash-strapped Labour government cannot fold to every corporate lobbying campaign. But it ought to heed Soriot and ...

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six ...

The US pharmaceutical giant said it was raising UK prices to address “pricing inconsistencies compared to other developed ...

The FDA has accepted GSK’s application for priority review of gepotidacin, a first-in-class antibiotic for uncomplicated ...

India had refused accept demands from the UK and Switzerland for data exclusivity to protect generic pharma industry, with ...

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending ...

The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.

The FTSE 100 achieved a new closing high on Wednesday but eased on Thursday morning, with some of its bigger constituents going ex-dividend. Shares in miner Rio Tinto fell 3.4%, GSK lost 1.9%, BP fell ...